Cite
HARVARD Citation
Fazeli Farsani, S. et al. (2019). Preferential prescribing of linagliptin in type 2 diabetes patients in an expanded post‐marketing surveillance study in Japan. Journal of diabetes investigation. 10 (5), pp. 1246-1253. [Online].